tirzepatide for mcas Not all GLP-1s work the same way MCAS., Most patients do better on Tirzepatide, the dual incretin with both GLP-1 and GIP receptor agonists. But some mast cells just respond better to semaglutide. My experience using Tirzepatide with

The drugs are designed to mimic a protein that the body makes naturally when we eat

Results improve when you have: Coaching to keep you accountable and motivated Nutrition guidance to build sustainable eating habits Regular follow-up care to track progress and make timely adjustments Some patients explore alternatives like tirzepatide if theyre looking for potentially greater weight loss or if semaglutide isnt the best fit for their health profile

Nutritional Priorities to Support GLP-1 Therapy for Obesity. *American Journal of Clinical Nutrition*, 2025

The right dose is the one that achieves your goals with the fewest side effects